Cevec Raises $8.5M to Commercialize Human Cell-Expression Platform for producing Proteins and Vaccines
July 28th, 2011
No comments
Firm aims to exploit human amniocyte-derived cell lines through new vaccine development partnerships Read more…
Categories: Cevec Pharmaceuticals, Financing
